{"id":"W2954147811","doi":"10.1016/j.euo.2019.06.002","title":"Can Biomarkers Guide the Use of Neoadjuvant Chemotherapy in T2 Bladder Cancer?","year":2019,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Roche; Merck","keywords":"Cystectomy; Medicine; Bladder cancer; Chemotherapy; Cisplatin; Oncology; Guideline; Cancer; Neoadjuvant therapy; Internal medicine; Clinical trial; DNA Damage Repair; DNA repair; Pathology; Gene; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005391314,0.0005952558,0.001684409,0.001637583,0.0004052712,0.002811011,0.0008977807,0.002136199,0.00363524],"category_scores_gemma":[0.01672168,0.0003057999,0.0009954609,0.00136379,0.0008130001,0.002875765,0.0007619315,0.002960714,0.002791434],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009148908,"about_ca_system_score_gemma":0.001715131,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002571795,"about_ca_topic_score_gemma":0.005970267,"domain_scores_codex":[0.9985508,0.0006947827,0.0002669458,0.0001250142,0.0002608889,0.0001014852],"domain_scores_gemma":[0.9928596,0.00277303,0.001222053,0.0002835669,0.002479726,0.0003821181],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001432623,0.0003490732,0.1893284,0.002892332,0.0004868964,0.0008191279,0.0003505213,0.002422415,0.003799171,0.005305676,0.1269019,0.6659118],"study_design_scores_gemma":[0.0005286654,0.002266233,0.2045747,0.01942967,0.001702615,0.00617857,0.002903672,0.009917567,0.007626629,0.05447841,0.6899817,0.0004115393],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.0744948,0.5640393,0.03159428,0.2762461,0.0100181,0.0006450136,0.003675734,0.0006699144,0.0386168],"genre_scores_gemma":[0.5382606,0.2747181,0.08303712,0.07390491,0.0114691,0.0009328062,0.005098484,0.0002906263,0.01228816],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.005391314,"threshold_uncertainty_score":0.02851236,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03674697873142426,"score_gpt":0.3119977905155355,"score_spread":0.2752508117841113,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}